Catalyst Pharmaceuticals, Inc. filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-07-16. Each change below is quoted from the filing and linked to it.
Every change, newest first
Reported
These resignations were not a result of any disagreement between the Company and the directors on any matter relating to the Company's operations, policies or practices.
Reported
In connection with the anticipated consummation of the Merger and as contemplated by the Merger Agreement, each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
Find people with the same kind of experience as the senior executive at Catalyst Pharmaceuticals, Inc., with the record behind each one.
Find candidates like senior executive at Catalyst Pharmaceuticals, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Catalyst Pharmaceuticals, Inc. is in the news or changes leadership.
Get an alert when Catalyst Pharmaceuticals, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Catalyst Pharmaceuticals, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.